AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 10,890 | +39.8% | 0.00% | – |
| Q2 2022 | $1,000 | -75.0% | 7,790 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 7,790 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -69.2% | 7,790 | 0.0% | 0.00% | – |
| Q3 2021 | $13,000 | 0.0% | 7,790 | 0.0% | 0.00% | – |
| Q2 2021 | $13,000 | -23.5% | 7,790 | -20.4% | 0.00% | – |
| Q1 2021 | $17,000 | +41.7% | 9,790 | +25.7% | 0.00% | – |
| Q4 2020 | $12,000 | +71.4% | 7,790 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | +40.0% | 7,790 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +66.7% | 7,790 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -40.0% | 7,790 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | +25.0% | 7,790 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | +33.3% | 7,790 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -25.0% | 7,790 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 7,790 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | – | 7,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shilanski & Associates, Inc. | 937,237 | $57,000 | 0.02% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $57,000 | 0.02% |
| CVA Family Office, LLC | 1,137,920 | $69,000 | 0.02% |
| Cypress Capital Management LLC (WY) | 140,925 | $9,000 | 0.01% |
| Helen Stephens Group, LLC | 117,222 | $7,000 | 0.01% |
| COURIER CAPITAL LLC | 540,056 | $33,000 | 0.00% |
| NORTHCAPE WEALTH MANAGEMENT, LLC | 98,000 | $6,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 10,000 | $1,000 | 0.00% |
| Western Wealth Management, LLC | 352,950 | $11,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 606,800 | $37,000 | 0.00% |